logo

For the Inventor, By the Inventor

FR

Flamel Technologies


USPTO Granted Patents = 50



Trademarks = 1

Forward Citations = 1,363

Loading Chart...
Loading Chart...

45 inventors (with patents filed for the assignee):

goldMedal Remi Meyrueix (11 out of 17 patents)

silverMedal Florence Guimberteau (9 out of 23 patents)

bronzeMedal You-Ping Chan (9 out of 41 patents)

4.  Gerard Soula (9 out of 61 patents)

5.  Catherine Castan (9 out of 15 patents)

6.  Gérard Soula (8 out of 14 patents)

7.  Rémi Meyrueix (7 out of 10 patents)

8.  Olivier Breyne (7 out of 22 patents)

9.  Nathan J Bryson (6 out of 8 patents)

10.  Olivier Soula (5 out of 33 patents)

11.  Florence Nicolas (5 out of 5 patents)

12.  Alain Constancis (4 out of 10 patents)

13.  Rémi Soula (4 out of 6 patents)

14.  Gerard Mignani (4 out of 41 patents)

15.  Gilles Hugues Tapolsky (4 out of 4 patents)


Core Competencies:
Prolonged Release
Microcapsules
Oral Pharmaceutical Formulations
Anti-Misuse Systems
Polyamino Acids
Therapeutic Applications
Colloidal Suspensions
Controlled Release
Guanidine Derivatives
Aerosol Compositions
Biomaterials
Nonlinear Optics

50 patents:

1. 9233993 - N-phosphonomethylglycine guanidine derivative salts (2016-01-12),
2. 9023400 - Prolonged-release multimicroparticulate oral pharmaceutical form (2015-05-05),
3. 8895063 - Oral dosage form comprising an antimisuse system (2014-11-25),
4. 8821935 - Microcapsules with modified release of active principles with low solubility for oral delivery (2014-09-02),
5. 8734850 - Oral medicinal product with modified release of at least one active principle in multimicrocapsular form (2014-05-27),
6. 8679540 - Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications (2014-03-25),
7. 8652529 - Anti-misuse microparticulate oral pharmaceutical form (2014-02-18),
8. 8652523 - Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility (2014-02-18),
9. 8507003 - Compressed tablets comprising microcapsules with modified release (2013-08-13),
10. 8481019 - Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof (2013-07-09),
11. 8445023 - Anti-misuse microparticulate oral pharmaceutical form (2013-05-21),
12. 8293255 - Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes (2012-10-23),
13. 8236353 - Self-precipitating pharmaceutical formulations for the modified release of an active principle (2012-08-07),
14. 8206744 - Branched polyamino acids functionalized with hydrophobic groups, and applications thereof particularly therapeutic applications (2012-06-26),
15. 8197850 - Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same (2012-06-12),
Flamel Technologies is a specialty pharmaceutical company focused on the development and commercialization of innovative drug products utilizing its proprietary drug delivery technology. The company specializes in the development of extended-release formulations of existing drugs and the development of new chemical entities.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

50 Patents

#27 in

#461 in France

#13,579 in the World

...
FR

Flamel Technologies

Forward Citations = 1,363

45 inventors:

goldMedal Remi Meyrueix (11 out of 17 patents)

silverMedal Florence Guimberteau (9 out of 23 patents)

bronzeMedal You-Ping Chan (9 out of 41 patents)

4.  Gerard Soula (9 out of 61 patents)

5.  Catherine Castan (9 out of 15 patents)

Please report any incorrect information to support@idiyas.com
Loading…